Adverse drug reactions of spontaneous reports in Shanghai pediatric population

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Li, Hui ^a   Guo, Xiao Jing ^a   Ye, Xiao Fei ^a   Jiang, Hong ^a   Du, Wen Min ^b   Xu, Jin Fang ^a   Zhang, Xin Ji ^a   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Adverse Drug Reaction Monitoring Centre of Shanghai   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMBROXOL; AMOXICILLIN; AZITHROMYCIN; BCG VACCINE; CEFOTAXIME; CEFOTIAM; CEFRADINE; CEFTRIAXONE; CEFUROXIME; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; LAMOTRIGINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G; PREDNISONE; TERBUTALINE SULFATE; VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ANAPHYLACTIC SHOCK; ARTICLE; BACTERIAL INFECTION; CHILD; CHINA; CLINICAL ARTICLE; CONVULSION; DIARRHEA; DISEASE SEVERITY; DRUG EFFECT; DRUG FATALITY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DYSPNEA; ENCEPHALITIS; FEMALE; FEVER; HAND FOOT AND MOUTH DISEASE; HUMAN; IATROGENIC DISEASE; INFANT; INTERSTITIAL PNEUMONIA; MALE; MEDICAL DOCUMENTATION; NEWBORN; PNEUMONIA; RASH; SPONTANEOUS REPORTING SYSTEM; VOMITING; AGE; CONSUMER; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EPIDEMIOLOGY; PRESCHOOL CHILD; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CHINA; CONSUMER PARTICIPATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; SEX FACTORS; VACCINES;

EID: 84896089082     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089829     Document Type: Article

References (39)

1. Van Puijenbroek EP, Egberts AC, Meyboom RH, Leufkens HG (1999) Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. Br J Clin Pharmacol 47: 689-693. (Pubitemid 29257668)
2. Kongkaew C, Noyce PR, Ashcroft DM (2008) Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 42: 1017-1025.
3. Pirmohamed M, James S, Meakin S, Green C, Scott AK, et al. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329: 15-19. (Pubitemid 38869995)
4. Smyth RM, Gargon E, Kirkham J, Cresswell L, Golder S, et al. (2012) Adverse drug reactions in children-a systematic review. PLoS One 7: e24061.
5. Lacoste-Roussillon C, Pouyanne P, Haramburu F, Miremont G, Begaud B (2001) Incidence of serious adverse drug reactions in general practice: a prospective study. Clin Pharmacol Ther 69: 458-462. (Pubitemid 32554552)
6. Easton KL, Chapman CB, Brien JA (2004) Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol 57: 611-615. (Pubitemid 38582181)
7. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, et al. (2001) Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52: 77-83. (Pubitemid 32862772)
8. Sturkenboom MC, Verhamme KM, Nicolosi A, Murray ML, Neubert A, et al. (2008) Drug use in children: cohort study in three European countries. BMJ 337: a2245.
9. Sammons HM, Choonara I (2005) Clinical trials of medication in children, 1996-2002. Eur J Clin Pharmacol 61: 165-167.
10. Conroy S, McIntyre J, Choonara I, Stephenson T (2000) Drug trials in children: problems and the way forward. Br J Clin Pharmacol 49: 93-97. (Pubitemid 30068285)
11. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279: 1200-1205. (Pubitemid 28193431)
12. Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC (2004) Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf 27: 819-829. (Pubitemid 39243563)
13. Clavenna A, Berti A, Gualandi L, Rossi E, De Rosa M, et al. (2009) Drug utilisation profile in the Italian paediatric population. Eur J Pediatr 168: 173-180.
14. Wysowski DK, Swartz L (2005) Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch Intern Med 165: 1363-1369. (Pubitemid 40973418)
15. Wiholm B-E, Olsson S, Moore N, Waller P (2000) Spontaneous reporting systems outside the US. In: Strom BL, editor. Pharmacoepidemiology. 3rd ed. Chichester: John Wiley & Sons, Chichester, UK. 175-192.
16. Committee of Chinese Pharmacopoeia (2005) Chinese Pharmacopoeia. Peking: Chemical Industry Press.
17. Ministry of Health of The People's Republic of China (2011) Measures for the Reporting and Monitoring of Adverse Drug Reactions definitions. Available: http://www.sfda.gov.cn/WS01/CL0053/62621.html. Accessed 2012 May 17.
18. Wallerstedt SM, Brunlof G, Sundstrom A (2011) Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register. Drug Saf 34: 669-682.
19. Noren GN, Sundberg R, Bate A, Edwards IR (2008) A statistical methodology for drug-drug interaction surveillance. Stat Med 27: 3057-3070.
20. Thakrar BT, Grundschober SB, Doessegger L (2007) Detecting signals of drug-drug interactions in a spontaneous reports database. Br J Clin Pharmacol 64: 489-495. (Pubitemid 47404296)
21. van Grootheest K, de Graaf L, de Jong-van den Berg LT (2003) Consumer adverse drug reaction reporting: a new step in pharmacovigilance Drug Saf 26: 211-217.
22. Aagaard L, Weber CB, Hansen EH (2010) Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf 33: 327-339.
23. Kimland E, Rane A, Ufer M, Panagiotidis G (2005) Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf 14: 493-499. (Pubitemid 40990744)
24. Carleton BC, Smith MA, Gelin MN, Heathcote SC (2007) Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol 14: e45-57.
25. Horen B, Montastruc JL, Lapeyre-Mestre M (2002) Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 54: 665-670. (Pubitemid 36002596)
26. Choonara I, Conroy S (2002) Unlicensed and off-label drug use in children: implications for safety. Drug Saf 25: 1-5. (Pubitemid 34208327)
27. Jain SS, Bavdekar SB, Gogtay NJ, Sadawarte PA (2008) Off-label drug use in children. Indian J Pediatr 75: 1133-1136.
28. Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, et al. (2000) Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 49: 158-167. (Pubitemid 30068294)
29. Sanchez Munoz-Torrero JF, Barquilla P, Velasco R, Fernandez Capitan Mdel C, Pacheco N, et al. (2010) Adverse drug reactions in internal medicine units and associated risk factors. Eur J Clin Pharmacol 66: 1257-1264.
30. Star K, Noren GN, Nordin K, Edwards IR (2011) Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf 34: 415-428.
31. Morales-Olivas FJ, Martinez-Mir I, Ferrer JM, Rubio E, Palop V (2000) Adverse drug reactions in children reported by means of the yellow card in Spain. J Clin Epidemiol 53: 1076-1080.
32. Le J, Nguyen T, Law AV, Hodding J (2006) Adverse drug reactions among children over a 10-year period. Pediatrics 118: 555-562. (Pubitemid 46085410)
33. Hawcutt DB, Mainie P, Riordan A, Smyth RL, Pirmohamed M (2011) Reported paediatric adverse drug reactions in the UK 2000-2009. Br J Clin Pharmacol 73: 437-446.
34. Rambhade S, Chakarborty A, Shrivastava A, Patil UK, Rambhade A (2012) A survey on polypharmacy and use of inappropriate medications. Toxicol Int 19: 68-73.
35. Koh NY, Koo WH (2002) Polypharmacy in palliative care: can it be reduced? Singapore Med J 43: 279-283.
36. Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H (2008) Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf 31: 789-798.
37. Rashed AN, Wong IC, Cranswick N, Tomlin S, Rascher W, et al. (2012) Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. Eur J Clin Pharmacol 68: 801-810.
38. van Grootheest AC, Passier JL, van Puijenbroek EP (2005) [Direct reporting of side effects by the patient: favourable experience in the first year]. Ned Tijdschr Geneeskd 149: 529-533.
39. KILEN (2000) Consumer Reports on Medicines-Consensus Document. Available: http://www.kilen.org/indexe.htm Accessed 2012 May 17.